Markets:

Overview

News

Currencies

International

Treasuries

Ocugen, Inc. - Common Stock (NQ:OCGN)

1.385 -0.075 (-5.14%)

Streaming Delayed Price Updated: 3:26 PM EDT, May 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

36 37 Next >

This 28% Short Biotech Company Has A Better 1-Year Return Than AMC, Snap, Apple And Tesla ↗

September 07, 2021

An investment in Ocugen Inc (NASDAQ: OCGN) one year ago is undoubtedly a sight for sore eyes. Since January 2021, Ocugen stock's year-to-date return has outperformed a number...

Via Benzinga

Ocugen Should Hit $9 If Its Covid-19 Vaccine Gets Approved ↗

September 01, 2021

There's no revenue yet for Ocugen, but OCGN stock could be worth 19% higher if its Covid-19 vaccine gets the thumbs up.

Via InvestorPlace

Ocugen Stock Will Suffer Its Inevitable Demise Sooner Rather Than Later ↗

September 01, 2021

At some point, the music will stop for OCGN stock, but for now, there's still plenty at play to keep it at inflated prices.

Via InvestorPlace

Ocugen Stock Seems Unattractive With Regulatory Uncertainties ↗

August 31, 2021

OCGN stock is unattractive as regulatory approval delays have limited the revenue and cash flow potential for the Covid-19 vaccine.

Via InvestorPlace

Ocugen Stock Doesn’t Have Short-Term Catalysts Needed To Make It a Buy ↗

August 30, 2021

OCGN stock is interesting once again as concerns regarding the Delta variant mount. But that should not be your sole reason to invest in Ocugen.

Via InvestorPlace

Atossa Therapeutics May Look Tempting, but There’s No Reason to Get in Now ↗

August 30, 2021

ATOS stock has some exciting points, but its story sends a message investors have heard, namely the price of progress is dilution.

Via InvestorPlace

The Odds Are Firmly Against Ocugen Stock Now ↗

August 27, 2021

OCGN stock is a remarkably risky Covid-19 vaccine play, as the company faces a myriad of regulatory roadblocks on different fronts.

Via InvestorPlace

August 25, 2021

Not every stock on the popular trading app is worth owning.

Via The Motley Fool

Vaccine Victory ↗

August 24, 2021

Monday the US stock market moved into further robust mode fueled by official FDA approval of the Pfizer and BioNTech COVID-19 vaccines. Will the momentum last through to Thursday when the Fed's Jackson...

Via Talk Markets

Topics Economy

Cynicism and Conspiracy Theories Could Help Ocugen ↗

August 24, 2021

While OCGN stock seems well behind the vaccination race to be worth a shot, there is one narrative that could potentially help.

Via InvestorPlace

Now That The FDA Approved Pfizer-BioNTech, Is This It For Vaccine Stocks? ↗

August 23, 2021

If there's one thing to take away from any conversation about biotech stocks, it's that any company with their hat in the ring is likely making a version of something they hope to be better than the...

Via Talk Markets

Ocugen’s Facing a Major Uphill Climb Without FDA Approval ↗

August 23, 2021

OCGN stock will be hard pressed to push any higher in the absence of good news

Via InvestorPlace

Ocugen Stock Is Well-Positioned, But Investors Want Results ↗

August 23, 2021

The company's latest business update sounds all fine and good, but OCGN stock holders want to see some action, not just words.

Via InvestorPlace

Ocugen Stock Still Looks Poised to Tumble ↗

August 23, 2021

Ocugen's apparent failure to prepare a U.S. trial for Covaxin, which will likely be necessary for FDA approval, bodes badly for OCGN stock.

Via InvestorPlace

Ocugen Stock Remains an All or Nothing Wager You Shouldn’t Make ↗

August 20, 2021

With limited upside from both its booster shot and Canada EUA catalysts, it's still best to avoid/sell OCGN stock.

Via InvestorPlace

Analyzing Ocugen's Unusual Options Activity ↗

August 19, 2021

Ocugen (NASDAQ:OCGN) shares experienced unusual options activity on Thursday. The stock price moved down to $6.92 following the option alert. Sentiment: BULLISH Option Type:...

Via Benzinga

LAWSUITS FILED AGAINST OCGN, DKNG and PLL - Jakubowitz Law Pursues Shareholders Claims

August 17, 2021

NEW YORK, NY / ACCESSWIRE / August 17, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies...

From Jakubowitz Law

Via AccessWire

Topics Fraud Lawsuit

CLASS ACTION UPDATE for OCGN, HMPT and ARDX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

August 16, 2021

NEW YORK, NY / ACCESSWIRE / August 16, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies....

From Levi & Korsinsky, LLP

Via AccessWire

Topics Lawsuit

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SRAC, OCGN and OTLY

August 16, 2021

NEW YORK, NY / ACCESSWIRE / August 16, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies....

From The Gross Law Firm

Via AccessWire

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of OCGN, AHCO and ATVI

August 15, 2021

NEW YORK, NY / ACCESSWIRE / August 15, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies....

From The Gross Law Firm

Via AccessWire

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Ocugen, Inc. and Encourages Investors to Contact the Firm

August 13, 2021

From Bragar Eagel & Squire, P.C.

Via Business Wire

LAWSUITS FILED AGAINST OCGN, DKNG and BZ - Jakubowitz Law Pursues Shareholders Claims

August 13, 2021

NEW YORK, NY / ACCESSWIRE / August 13, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies...

From Jakubowitz Law

Via AccessWire

Topics Fraud Lawsuit

Ocugen Now Relies Solely on A Continued COVID-19 Crisis ↗

August 13, 2021

OCGN stock is a mix of irrational exuberance related to its valuation, unrealistic hopes, continuous speculation and very poor fundamentals.

Via InvestorPlace

CLASS ACTION UPDATE for OCGN, REKR and BLCT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

August 13, 2021

NEW YORK, NY / ACCESSWIRE / August 13, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies....

From Levi & Korsinsky, LLP

Via AccessWire

Topics Lawsuit

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ocugen, Inc. (OCGN)

August 13, 2021

From The Law Offices of Frank R. Cruz

Via Business Wire

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OCGN, BLCT and OTLY

August 13, 2021

NEW YORK, NY / ACCESSWIRE / August 13, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to...

From The Klein Law Firm

Via AccessWire

Topics Fraud Lawsuit

SHAREHOLDER ALERT: OCGN BZ PLL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

August 12, 2021

NEW YORK, NY / ACCESSWIRE / August 12, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a...

From The Law Offices of Vincent Wong

Via AccessWire

Topics Fraud

Do mRNA COVID-19 Vaccines Cause Skin Or Kidney Disorders? EMA Investigates Possible Links ↗

August 12, 2021

The European Medicines Agency is investing a possible link between mRNA vaccines and erythema multiforme or two kidney disorders by a few recipients of the shots....

Via Benzinga

CLASS ACTION UPDATE for OCGN, RKT and BZ: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

August 12, 2021

NEW YORK, NY / ACCESSWIRE / August 12, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies....

From Levi & Korsinsky, LLP

Via AccessWire

Topics Lawsuit

OCGN Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Ocugen, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm

August 12, 2021

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

36 37 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.